ATE194915T1 - Intranasales antimigränemittel - Google Patents

Intranasales antimigränemittel

Info

Publication number
ATE194915T1
ATE194915T1 AT95916618T AT95916618T ATE194915T1 AT E194915 T1 ATE194915 T1 AT E194915T1 AT 95916618 T AT95916618 T AT 95916618T AT 95916618 T AT95916618 T AT 95916618T AT E194915 T1 ATE194915 T1 AT E194915T1
Authority
AT
Austria
Prior art keywords
medicine
antimigraine
intranasales
composition
spray device
Prior art date
Application number
AT95916618T
Other languages
English (en)
Inventor
Marc Karel Jozef Francois
Roger Carolus August Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE194915T1 publication Critical patent/ATE194915T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95916618T 1994-04-13 1995-04-10 Intranasales antimigränemittel ATE194915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (1)

Publication Number Publication Date
ATE194915T1 true ATE194915T1 (de) 2000-08-15

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916618T ATE194915T1 (de) 1994-04-13 1995-04-10 Intranasales antimigränemittel

Country Status (23)

Country Link
EP (1) EP0755253B1 (de)
JP (1) JP2921988B2 (de)
KR (1) KR100219952B1 (de)
CN (1) CN1146151A (de)
AT (1) ATE194915T1 (de)
AU (1) AU684360B2 (de)
BG (1) BG62197B1 (de)
BR (1) BR9507369A (de)
CA (1) CA2184822C (de)
CZ (1) CZ286610B6 (de)
DE (1) DE69518149T2 (de)
FI (1) FI118295B (de)
HR (1) HRP950149A2 (de)
HU (1) HU219495B (de)
IL (1) IL113341A (de)
NO (1) NO310276B1 (de)
NZ (1) NZ284454A (de)
PL (1) PL179761B1 (de)
RO (1) RO115414B1 (de)
SI (1) SI9500121A (de)
SK (1) SK129896A3 (de)
WO (1) WO1995028158A1 (de)
ZA (1) ZA953038B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403905D0 (sv) * 1994-11-14 1994-11-14 Astra Ab New formulations
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
NL2022788B1 (en) * 2019-03-22 2020-09-28 No Ceuticals B V Chitosan nitrate for use as a nitric oxide donor (NO donor)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
BR9507369A (pt) 1997-09-23
IL113341A (en) 2000-08-31
DE69518149D1 (de) 2000-08-31
NZ284454A (en) 1997-12-19
SK129896A3 (en) 1997-05-07
KR100219952B1 (ko) 1999-09-01
HUT75939A (en) 1997-05-28
BG62197B1 (bg) 1999-05-31
ZA953038B (en) 1996-10-14
WO1995028158A1 (en) 1995-10-26
JPH09505606A (ja) 1997-06-03
DE69518149T2 (de) 2001-03-22
AU684360B2 (en) 1997-12-11
PL316756A1 (en) 1997-02-03
CN1146151A (zh) 1997-03-26
CA2184822A1 (en) 1995-10-26
NO310276B1 (no) 2001-06-18
FI118295B (fi) 2007-09-28
BG100889A (en) 1997-07-31
CZ286610B6 (cs) 2000-05-17
FI964095L (fi) 1996-10-11
FI964095A0 (fi) 1996-10-11
HRP950149A2 (en) 1997-06-30
PL179761B1 (pl) 2000-10-31
CZ292096A3 (en) 1997-02-12
HU219495B (hu) 2001-04-28
NO964333D0 (no) 1996-10-11
CA2184822C (en) 2000-12-19
HU9602806D0 (en) 1996-11-28
EP0755253A1 (de) 1997-01-29
RO115414B1 (ro) 2000-02-28
JP2921988B2 (ja) 1999-07-19
SI9500121A (en) 1995-10-31
NO964333L (no) 1996-10-11
IL113341A0 (en) 1995-07-31
EP0755253B1 (de) 2000-07-26
AU2305495A (en) 1995-11-10

Similar Documents

Publication Publication Date Title
MY113733A (en) Salts of an anti-migraine indole derivative
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
MX9601360A (es) Mezcla estabilizante sinergistica.
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
DE60220887D1 (de) Agonisten von beta-adrenorezeptoren
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
NO964333L (no) Intranasal antimigrenesammensetning
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
DE69740060D1 (de) Nasale verabreichung von substanzen zur behandlung der tardiven emesis
MX9604690A (es) Composicion antimigraña intranasal.
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
MX9701764A (es) Derivados de imidoacidos.
MXPA04006085A (es) Compuestos de isocromano para el tratamiento de trastornos del sistema nervioso central.
ES2170377T3 (es) Composicion que contiene quitosana.
WO2002070069A3 (fr) Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque
PL353291A1 (en) Novel compounds, method of obtaining them, their application as pigments and composition containing them
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
MX9702486A (es) La fabricacion de levobupivacaina y sus analogos de l-lisina.
IL122537A0 (en) Arylalkoxyphenoxy-imidazoline compounds process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification